local_hospital

Spitalul Clinic De Urgenta Pentru Copii Cluj-Napoca

Address
lock Available on a paid plan

Spitalul Clinic De Urgenta Pentru Copii Cluj-Napoca - Pediatric Nephrology Research

Spitalul Clinic De Urgenta Pentru Copii Cluj-Napoca is a specialized pediatric emergency clinical hospital actively engaged in advanced clinical research focusing on chronic kidney disease management in children and adolescents. The center demonstrates particular expertise in investigating novel therapeutic approaches for complications arising from pediatric renal disorders.

  • Anemia management in pediatric chronic kidney disease patients
  • Pharmacokinetic and pharmacodynamic studies in children and adolescents
  • Novel anemia therapies including roxadustat treatment evaluation

The institution's research portfolio emphasizes evaluation of activity and safety profiles of emerging treatments for anemia associated with chronic kidney disease in the pediatric population. Through participation in Phase 3 clinical trials, the center contributes valuable data on treatment outcomes, helping to establish therapeutic options specifically tailored for children suffering from renal-related hematological complications.

Site Overview

assignment
8
connected trials
corporate_fare
8
sponsors
science
12
IMPs

Activity Indicator

Last 6 months

1
Trials started
0% vs previous period.
1
Trials started 6–12 months ago
8
Total trials linked
Active
trending_flatStable0%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 5 of 6 therapeutic areas and 11 of 12 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
8
Sponsors (total)
8
Active sponsors
8

Sponsor Network

Top 8 by active trials.

lock +7 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 442 other sites in Romania

description
Trial volume
8
Outperforms 73% of sites
public
Therapeutic diversity
6areas
Outperforms 90% of sites
groups
Sponsor diversity
8sponsors
Outperforms 81% of sites

Therapeutic Area Benchmark — Romania

Select a therapeutic area to compare against other sites in Romania.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Romania

Market Share

Country: Romania

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Spitalul Clinic De Urgenta Pentru Copii Cluj-Napoca

lock Showing 1 of 8 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Phase 3, Open-label, Uncontrolled Study to Evaluate the Activity, Safety, Pharmacokinetics and Pharmacodynamics of Roxadustat for the Treatment of Anemia in Pediatric Participants with Chronic Kidney DiseaseAstellas Pharma Global Development Inc.Phase IIIRecruitingDec 2023

IMP list

lock Showing 1 of 12 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Apremilast1Unknown2021-03-312021-03-31

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.